Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1818

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 1818
---
 404 of SEC Regulation S-K, a related person transaction is any actual or proposed transaction, arrangement or relationship or series
of similar transactions, arrangements or relationships, including those involving indebtedness not in the ordinary course of business,
to which we or our subsidiaries were or are a party, or in which we or our subsidiaries were or are a participant, in which the amount
involved exceeded or exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal
years and in which any of our directors, nominees for director, executive officers, beneficial owners of more than 5% of any class of
our voting securities, or any member of the immediate family of any of the foregoing persons, had or will have a direct or indirect material
interest.

We
recognize that transactions between us and any of our directors or executives or with a third party in which one of our officers, directors
or significant shareholders has an interest can present potential or actual conflicts of interest and create the appearance that our
decisions are based on considerations other than the best interests of our Company and stockholders.

118

The
Audit Committee of the Board of Directors is charged with responsibility for reviewing, approving and overseeing any transaction between
the Company and any related person (as defined in Item 404 of Regulation S-K), including the propriety and ethical implications of any
such transactions, as reported or disclosed to the Audit Committee by the independent auditors, employees, officers, members of the Board
of Directors or otherwise, and to determine whether the terms of the transaction are not less favorable to us than could be obtained
from an unaffiliated party

From
time to time, we engage in transactions with related parties. The following is a summary of the related party transactions for the fiscal
years ended December 31, 2024 and 2023 requiring disclosure pursuant to Item 404 of Regulation S-K.

Notes
Payable, related party

The
Company’s Chief Executive Officer (CEO) has loaned the Company working capital since inception. The balance of the loans to the
CEO as of December 31, 2024 and 2023 was $146,432 and $358,479, respectively. The loan is due on demand and accrues interest at 3% per
year. Accrued interest relating to the loan was $1,064 and $11,308 as of December 31, 2024 and 2023